182 related articles for article (PubMed ID: 34397195)
1. Characteristics of Superficial Basal Cell Carcinomas Containing More Aggressive Subtypes on Final Histopathologic Diagnosis.
Sohn GK; Keniston K; Kannan S; Hinds B; Jian SIB
J Drugs Dermatol; 2021 Aug; 20(8):874-879. PubMed ID: 34397195
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of Superficial Basal Cell Carcinomas Containing More Aggressive Subtypes on Final Histopathologic Diagnosis.
Sohn GK; Keniston K; Kannan S; Hinds B; Jiang SIB
J Drugs Dermatol; 2021 Mar; 20(3):283-288. PubMed ID: 33683071
[TBL] [Abstract][Full Text] [Related]
3. Correlation of basal cell carcinoma subtype with histologically confirmed subclinical extension during Mohs micrographic surgery: A prospective multicenter study.
Lim GF; Perez OA; Zitelli JA; Brodland DG
J Am Acad Dermatol; 2022 Jun; 86(6):1309-1317. PubMed ID: 35231546
[TBL] [Abstract][Full Text] [Related]
4. Nonpersistence of basal cell carcinoma after diagnostic shave biopsy: reconstruction when specimen is negative during surgery.
Gurunluoglu R; Kubek E; Arton J; Olsen A; Bronsert M
Ann Plast Surg; 2015 Jun; 74(6):695-8. PubMed ID: 25969972
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of Biopsy in Subtyping Periocular Basal Cell Carcinoma.
Sun MT; Wu A; Huilgol SC; Selva D
Ophthalmic Plast Reconstr Surg; 2015; 31(6):449-51. PubMed ID: 25794023
[TBL] [Abstract][Full Text] [Related]
6. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
Hendrix JD; Parlette HL
Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of punch biopsy in subtyping basal cell carcinoma.
Kamyab-Hesari K; Seirafi H; Naraghi ZS; Shahshahani MM; Rahbar Z; Damavandi MR; Naraghi MM; Rezvani M; Aghazadeh N
J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):250-3. PubMed ID: 22989368
[TBL] [Abstract][Full Text] [Related]
8. Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas.
Betti R; Menni S; Radaelli G; Bombonato C; Crosti C
J Dermatol; 2010 Jul; 37(7):611-6. PubMed ID: 20629826
[TBL] [Abstract][Full Text] [Related]
9. Superficial basal cell carcinoma, think deeper: Step sectioning of skin biopsy specimens yields 14% more aggressive subtypes.
El Sharouni MA; van Diest PJ; Blokx WAM
PLoS One; 2022; 17(1):e0256149. PubMed ID: 35051169
[TBL] [Abstract][Full Text] [Related]
10. Micronodular basal cell carcinoma. A deceptive histologic subtype with frequent clinically undetected tumor extension.
Hendrix JD; Parlette HL
Arch Dermatol; 1996 Mar; 132(3):295-8. PubMed ID: 8607634
[TBL] [Abstract][Full Text] [Related]
11. Biopsy type does not affect the number of stages during Mohs micrographic surgery: a retrospective study.
Araneda P; Donoso F; Castro JC; Uribe P; Rossi AM; Hibler BP; Droppelmann K; Cardenas C; Navarrete-Dechent C
Clin Exp Dermatol; 2023 Jun; 48(6):674-675. PubMed ID: 36805631
[TBL] [Abstract][Full Text] [Related]
12. Non-Melanoma Skin Cancer Tumor's Characteristics and Histologic Subtype as a Predictor for Subclinical Spread and Number of Mohs Stages required to Achieve Tumor-Free Margins.
Santos-Arroyo A; Carrasquillo OY; Cardona R; Sánchez JL; Valentín-Nogueras S
P R Health Sci J; 2019 Mar; 38(1):40-45. PubMed ID: 30924914
[TBL] [Abstract][Full Text] [Related]
13. Surgical margins required for basal cell carcinomas treated with Mohs micrographic surgery according to tumor features.
Cerci FB; Kubo EM; Werner B; Tolkachjov SN
J Am Acad Dermatol; 2020 Aug; 83(2):493-500. PubMed ID: 32289390
[TBL] [Abstract][Full Text] [Related]
14. Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: A retrospective study of 1021 cases.
Kuiper EM; van den Berge BA; Spoo JR; Kuiper J; Terra JB
Clin Otolaryngol; 2018 Oct; 43(5):1321-1327. PubMed ID: 29953746
[TBL] [Abstract][Full Text] [Related]
15. Misclassification of Aggressive Basal Cell Carcinoma Subtypes and Implications for Management.
Moon D; Randall G; Higgins S; Sutton AV; Wysong A
Dermatol Surg; 2021 May; 47(5):593-598. PubMed ID: 33905389
[TBL] [Abstract][Full Text] [Related]
16. Histopathological discrepancy between biopsy and Mohs micrographic surgery in keratinocyte carcinoma: A 464 case series in an Australian population.
Stewart N; Rodríguez Bandera AI; Lee S
Australas J Dermatol; 2021 Feb; 62(1):41-46. PubMed ID: 32808286
[TBL] [Abstract][Full Text] [Related]
17. Correlation of histologic subtypes of primary basal cell carcinoma and number of Mohs stages required to achieve a tumor-free plane.
Orengo IF; Salasche SJ; Fewkes J; Khan J; Thornby J; Rubin F
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):395-7. PubMed ID: 9308552
[TBL] [Abstract][Full Text] [Related]
18. Adamantinoid basal cell carcinoma: a predictor of more-aggressive clinical behavior.
Berk DR; Ball Arefiev KL; Gladstone HB
Dermatol Surg; 2012 Aug; 38(8):1346-50. PubMed ID: 22551358
[TBL] [Abstract][Full Text] [Related]
19. Basal cell carcinoma of the head region: therapeutical results of 350 lesions treated with Mohs micrographic surgery.
Veronese F; Farinelli P; Zavattaro E; Zuccoli R; Bonvini D; Leigheb G; Colombo E
J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):838-43. PubMed ID: 21707774
[TBL] [Abstract][Full Text] [Related]
20. Management of periocular basal cell carcinoma by Mohs micrographic surgery.
Litwin AS; Rytina E; Ha T; René C; Woodruff SA
J Dermatolog Treat; 2013 Jun; 24(3):232-4. PubMed ID: 22551161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]